A gene-editing company focused on developing transformative gene-based medicines.
2 AI-extracted insights from 2 sources — podcasts, YouTube channels, and X/Twitter accounts.
Not enough scored insights about CRISPR Therapeutics AG in the last 30 days yet.
The 2 sources with the most insights about CRISPR Therapeutics AG on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Highlighted as a publicly traded leader in CRISPR gene-editing technology, which is described as a major, real-world investment theme with significant potential for growth based on underlying health and biotech trends.
Mentioned as one of the heavily shorted, smaller-cap stocks that saw significant gains due to a 'risk-on' appetite and speculative fervor in the market.
Highlighted as a publicly traded leader in CRISPR gene-editing technology, which is described as a major, real-world investment theme with significant potential for growth based on underlying health and biotech trends.
Mentioned as one of the heavily shorted, smaller-cap stocks that saw significant gains due to a 'risk-on' appetite and speculative fervor in the market.
Other assets that creators frequently mention in the same content as CRISPR Therapeutics AG.
The most active sources covering CRISPR Therapeutics AG (CRSP) on Kazuha are @amitinvesting, Joe Rogan. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 2 AI-extracted insights about CRISPR Therapeutics AG (CRSP) from 2 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering CRISPR Therapeutics AG (CRSP) most frequently also discuss SBET, RXRX, ABCL, SQ, BA. See the "Discussed alongside" section above for full asset pages.